SNY vs. GILD
Compare and contrast key facts about Sanofi (SNY) and Gilead Sciences, Inc. (GILD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or GILD.
Key characteristics
| SNY | GILD | |
|---|---|---|
| YTD Return | -0.54% | -18.53% |
| 1Y Return | -5.21% | -14.53% |
| 3Y Return (Ann) | 1.63% | 3.95% |
| 5Y Return (Ann) | 6.53% | 3.57% |
| 10Y Return (Ann) | 2.89% | 1.07% |
| Sharpe Ratio | -0.14 | -0.72 |
| Daily Std Dev | 26.73% | 21.56% |
| Max Drawdown | -46.65% | -70.83% |
| Current Drawdown | -10.40% | -27.61% |
Fundamentals
| SNY | GILD | |
|---|---|---|
| Market Cap | $122.65B | $81.58B |
| EPS | $2.30 | $4.50 |
| PE Ratio | 21.36 | 14.54 |
| PEG Ratio | 0.84 | 0.42 |
| Revenue (TTM) | $46.29B | $27.45B |
| Gross Profit (TTM) | $31.70B | $21.62B |
| EBITDA (TTM) | $12.20B | $12.82B |
Correlation
The correlation between SNY and GILD is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. GILD - Performance Comparison
In the year-to-date period, SNY achieves a -0.54% return, which is significantly higher than GILD's -18.53% return. Over the past 10 years, SNY has outperformed GILD with an annualized return of 2.89%, while GILD has yielded a comparatively lower 1.07% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. GILD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. GILD - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 3.84%, less than GILD's 4.62% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 3.84% | 3.82% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.77% | 4.19% | 3.47% |
GILD Gilead Sciences, Inc. | 4.62% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% | 0.00% |
Drawdowns
SNY vs. GILD - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum GILD drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for SNY and GILD. For additional features, visit the drawdowns tool.
Volatility
SNY vs. GILD - Volatility Comparison
Sanofi (SNY) has a higher volatility of 8.00% compared to Gilead Sciences, Inc. (GILD) at 4.84%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities